{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:32:01Z","timestamp":1778740321568,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:00:00Z","timestamp":1584748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:00:00Z","timestamp":1584748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00210-020-01855-9","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T12:02:29Z","timestamp":1584792149000},"page":"1475-1485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Magnetic fields enhance the anti-tumor efficacy of low dose cisplatin and reduce the nephrotoxicity"],"prefix":"10.1007","volume":"393","author":[{"given":"Monira M.","family":"Rageh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa R.","family":"El-Garhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebtesam A.","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,21]]},"reference":[{"issue":"3","key":"1855_CR1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.phrs.2005.12.005","volume":"53","author":"AA Al-Majed","year":"2006","unstructured":"Al-Majed AA, Sayed-Ahmed MM, Al-Yahya AA, Aleisa AM, Al-Rejaie SS, Al-Shabanah OA (2006) Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model. Pharmacol Res 53(3):278\u2013286","journal-title":"Pharmacol Res"},{"key":"1855_CR2","doi-asserted-by":"crossref","unstructured":"Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. In: Seminars in Nephrology (vol 23, no 5, pp 460-464). WB Saunders","DOI":"10.1016\/S0270-9295(03)00089-5"},{"issue":"3","key":"1855_CR3","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3390\/cancers3033279","volume":"3","author":"M Arruebo","year":"2011","unstructured":"Arruebo M, Vilaboa N, S\u00e1ez-Gutierrez B, Lambea J, Tres A, Valladares M, Gonz\u00e1lez-Fern\u00e1ndez \u00c1 (2011) Assessment of the evolution of cancer treatment therapies. Cancers 3(3):3279\u20133330","journal-title":"Cancers"},{"issue":"4","key":"1855_CR4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10616-015-9900-y","volume":"68","author":"J Baharara","year":"2016","unstructured":"Baharara J, Hosseini N, Farzin TR (2016) Extremely low frequency electromagnetic field sensitizes cisplatin-resistant human ovarian adenocarcinoma cells via P53 activation. Cytotechnology 68(4):1403\u20131413","journal-title":"Cytotechnology"},{"issue":"7","key":"1855_CR5","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","volume":"217","author":"A Bansal","year":"2018","unstructured":"Bansal A, Simon MC (2018) Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol 217(7):2291\u20132298","journal-title":"J Cell Biol"},{"issue":"4","key":"1855_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/10408441003601836","volume":"40","author":"A Brozovic","year":"2010","unstructured":"Brozovic A, Ambriovi\u0107-Ristov A, Osmak M (2010) The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin. Crit Rev Toxicol 40(4):347\u2013359","journal-title":"Crit Rev Toxicol"},{"issue":"3","key":"1855_CR7","first-page":"490","volume":"21","author":"G Chen","year":"2017","unstructured":"Chen G (2017) The relationship between the expression of TAM, survivin and the degree of necrosis of the tumor after cisplatin treatment in osteosarcoma. Eur Rev Med Pharmacol Sci 21(3):490\u2013497","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"1855_CR8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/cbr.2009.0743","volume":"25","author":"WF Chen","year":"2010","unstructured":"Chen WF, Qi H, Sun RG, Liu Y, Zhang K, Liu JQ (2010) Static magnetic fields enhanced the potency of cisplatin on K562 cells. Cancer Biother Radiopharm 25(4):401\u2013408","journal-title":"Cancer Biother Radiopharm"},{"key":"1855_CR9","doi-asserted-by":"crossref","unstructured":"Chen X, Wei W, Li Y, Huang J, Ci X (2019) Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis. Chem Biol Interact","DOI":"10.1016\/j.cbi.2019.05.040"},{"issue":"2","key":"1855_CR10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11064-008-9760-3","volume":"34","author":"\u015e Co\u015fkun","year":"2009","unstructured":"Co\u015fkun \u015e, Balabanl\u0131 B, Canseven A, Seyhan N (2009) Effects of continuous and intermittent magnetic fields on oxidative parameters in vivo. Neurochem Res 34(2):238\u2013243","journal-title":"Neurochem Res"},{"key":"1855_CR11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.fct.2013.09.003","volume":"62","author":"R Domitrovi\u0107","year":"2013","unstructured":"Domitrovi\u0107 R, Cvijanovi\u0107 O, Pernjak-Pugel E, \u0160koda M, Mikeli\u0107 L, Crn\u010devi\u0107-Orli\u0107 \u017d (2013) Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative\/nitrosative stress, inflammation, autophagy and apoptosis. Food Chem Toxicol 62:397\u2013406","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"1855_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cbi.2007.07.014","volume":"170","author":"NAG Dos Santos","year":"2007","unstructured":"Dos Santos NAG, Martins NM, Curti C, Bianchi MDLP, dos Santos AC (2007) Dimethylthiourea protects against mitochondrial oxidative damage induced by cisplatin in liver of rats. Chem Biol Interact 170(3):177\u2013186","journal-title":"Chem Biol Interact"},{"issue":"9","key":"1855_CR13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/1061186X.2016.1191079","volume":"24","author":"YN Dou","year":"2016","unstructured":"Dou YN, Dunne M, Huang H, Mckee T, Chang MC, Jaffray DA, Allen C (2016) Thermosensitive liposomal cisplatin in combination with local hyperthermia results in tumor growth delay and changes in tumor microenvironment in xenograft models of lung carcinoma. J Drug Target 24(9):865\u2013877","journal-title":"J Drug Target"},{"key":"1855_CR14","doi-asserted-by":"publisher","unstructured":"El-Bialy NS, Rageh MM (2013) Extremely low-frequency magnetic field enhances the therapeutic efficacy of low-dose cisplatin in the treatment of Ehrlich carcinoma. BioMed Research International 2013:7. https:\/\/doi.org\/10.1155\/2013\/189352","DOI":"10.1155\/2013\/189352"},{"issue":"2","key":"1855_CR15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/157489206777442287","volume":"1","author":"M Galanski","year":"2006","unstructured":"Galanski M (2006) Recent developments in the field of anticancer platinum complexes. Recent patents on anti-cancer drug discovery 1(2):285\u2013295","journal-title":"Recent patents on anti-cancer drug discovery"},{"issue":"12","key":"1855_CR16","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12(12):931\u2013947","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1855_CR17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1006490226104","volume":"18","author":"JT Hartmann","year":"2000","unstructured":"Hartmann JT, Fels LM, Knop S, Stolte H, Kanz L, Bokemeyer C (2000) A randomized trial comparing the nephrotoxicity of cisplatin\/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors. Investig New Drugs 18(3):281\u2013289","journal-title":"Investig New Drugs"},{"issue":"1","key":"1855_CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13395-016-0098-2","volume":"6","author":"S Hatakeyama","year":"2016","unstructured":"Hatakeyama S, Summermatter S, Jourdain M, Melly S, Minetti GC, Lach-Trifilieff E (2016) ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments. Skelet Muscle 6(1):26","journal-title":"Skelet Muscle"},{"issue":"1\u20132","key":"1855_CR19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1006889427520","volume":"178","author":"K Husain","year":"1998","unstructured":"Husain K, Morris C, Whitworth C, Trammell GL, Rybak LP, Somani SM (1998) Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system. Mol Cell Biochem 178(1\u20132):127\u2013133","journal-title":"Mol Cell Biochem"},{"issue":"22","key":"1855_CR20","doi-asserted-by":"crossref","first-page":"14298","DOI":"10.1073\/pnas.162491399","volume":"99","author":"S Ishida","year":"2002","unstructured":"Ishida S, Lee J, Thiele DJ, Herskowitz I (2002) Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci 99(22):14298\u201314302","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"1855_CR21","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccr.2010.04.011","volume":"17","author":"S Ishida","year":"2010","unstructured":"Ishida S, McCormick F, Smith-McCune K, Hanahan D (2010) Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell 17(6):574\u2013583","journal-title":"Cancer Cell"},{"issue":"2","key":"1855_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1567-5394(02)00059-2","volume":"57","author":"J Jajte","year":"2002","unstructured":"Jajte J, Grzegorczyk J, Zmy\u015blony M, Rajkowska E (2002) Effect of 7 mT static magnetic field and iron ions on rat lymphocytes: apoptosis, necrosis and free radical processes. Bioelectrochemistry 57(2):107\u2013111","journal-title":"Bioelectrochemistry"},{"issue":"2","key":"1855_CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","volume":"108","author":"RW Johnstone","year":"2002","unstructured":"Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108(2):153\u2013164","journal-title":"Cell"},{"issue":"1","key":"1855_CR24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1109\/JERM.2018.2880341","volume":"3","author":"M Kakikawa","year":"2018","unstructured":"Kakikawa M, Maeda T, Yamada S (2018) Combined effect of 60 Hz magnetic fields and anticancer drugs on human Hepatoma HepG2 cells. IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology 3(1):56\u201360","journal-title":"IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology"},{"issue":"9","key":"1855_CR25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11626-017-0148-z","volume":"53","author":"S Kamalipooya","year":"2017","unstructured":"Kamalipooya S, Abdolmaleki P, Salemi Z, Jouni FJ, Zafari J, Soleimani H (2017) Simultaneous application of cisplatin and static magnetic field enhances oxidative stress in HeLa cell line. Vitro Cell Dev Biol Anim 53(9):783\u2013790","journal-title":"Vitro Cell Dev Biol Anim"},{"issue":"2","key":"1855_CR26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1159\/000501715","volume":"12","author":"T Kawahara","year":"2019","unstructured":"Kawahara T, Mochizuki T, Sugimura R, Izumi K, Kuroda S, Miyoshi Y, Nakaigawa N, Yao M, Tanabe M, Uemura H (2019) Successful resection of Cisplatin-resistant renal pelvic cancer after the administration of pembrolizumab as second-line therapy. Case Rep Oncol 12(2):548\u2013553","journal-title":"Case Rep Oncol"},{"issue":"3","key":"1855_CR27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.taap.2011.11.013","volume":"258","author":"R Khan","year":"2012","unstructured":"Khan R, Khan AQ, Qamar W, Lateef A, Tahir M, Rehman MU, Ali F, Sultana S (2012) Chrysin protects against cisplatin-induced colon. Toxicity via amelioration of oxidative stress and apoptosis: probable role of p38MAPK and p53. Toxicol Appl Pharmacol 258(3):315\u2013329","journal-title":"Toxicol Appl Pharmacol"},{"key":"1855_CR28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5053\/ejobios.2011.5.0.12","volume":"5","author":"LI Khayyat","year":"2011","unstructured":"Khayyat LI (2011) The histopathological effects of an electromagnetic field on the kidney and testis of mice. Eurasia J Biosci 5:103\u2013109","journal-title":"Eurasia J Biosci"},{"issue":"12","key":"1855_CR29","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/ndt\/12.12.2478","volume":"12","author":"MK Kuhlmann","year":"1997","unstructured":"Kuhlmann MK, Burkhardt G, K\u00f6hler H (1997) Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association-European Renal Association 12(12):2478\u20132480","journal-title":"Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association-European Renal Association"},{"issue":"1","key":"1855_CR30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1081\/JBC-100100300","volume":"19","author":"B Kula","year":"2000","unstructured":"Kula B, Sobczak A, Ku\u015bka R (2000) Effects of static and ELF magnetic fields on free-radical processes in rat liver and kidney. Electro Magnetobiol 19(1):99\u2013105","journal-title":"Electro Magnetobiol"},{"issue":"2","key":"1855_CR31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1081\/JBC-120006789","volume":"21","author":"B Kula","year":"2002","unstructured":"Kula B, Sobczak A, Ku\u015bka R (2002) A study of the effects of static and extremely low frequency magnetic fields on lipid peroxidation products in subcellular fibroblast fractions. Electromagnet Biol Med 21(2):161\u2013168","journal-title":"Electromagnet Biol Med"},{"issue":"6","key":"1855_CR32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1289\/ehp.6355","volume":"112","author":"H Lai","year":"2004","unstructured":"Lai H, Singh NP (2004) Magnetic-field-induced DNA strand breaks in brain cells of the rat. Environ Health Perspect 112(6):687\u2013694","journal-title":"Environ Health Perspect"},{"key":"1855_CR33","doi-asserted-by":"crossref","unstructured":"Lai HC, Singh NP (2010) Medical applications of electromagnetic fields. In: IOP Conference Series: Earth and Environmental Science (vol 10, no 1, p 012006). IOP Publishing","DOI":"10.1088\/1755-1315\/10\/1\/012006"},{"issue":"1","key":"1855_CR34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2009.02.016","volume":"48","author":"W Liao","year":"2009","unstructured":"Liao W, McNutt MA, Zhu WG (2009) The comet assay: a sensitive method for detecting DNA damage in individual cells. Methods 48(1):46\u201353","journal-title":"Methods"},{"issue":"3","key":"1855_CR35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00210-019-01734-y","volume":"393","author":"AO Maghmomeh","year":"2020","unstructured":"Maghmomeh AO, El-Gayar AM, El-Karef A, Abdel-Rahman N (2020) Arsenic trioxide and curcumin attenuate cisplatin-induced renal fibrosis in rats through targeting hedgehog signaling. Naunyn Schmiedeberg's Arch Pharmacol 393(3):303\u2013313","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"5","key":"1855_CR36","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0891-5849(97)00016-6","volume":"23","author":"R Meneghini","year":"1997","unstructured":"Meneghini R (1997) Iron homeostasis, oxidative stress, and DNA damage. Free Radic Biol Med 23(5):783\u2013792","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"1855_CR37","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00280-008-0924-2","volume":"64","author":"N Nakashima-Kamimura","year":"2009","unstructured":"Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S (2009) Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol 64(4):753\u2013761","journal-title":"Cancer Chemother Pharmacol"},{"issue":"12","key":"1855_CR38","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.3390\/molecules23123347","volume":"23","author":"N Nguyen","year":"2018","unstructured":"Nguyen N, Tran N, Le P, Nguyen T, Bach L, Doan V et al (2018) Synergic activity against MCF-7 breast cancer cell growth of nanocurcumin-encapsulated and cisplatin-complexed nanogels. Molecules 23(12):3347","journal-title":"Molecules"},{"issue":"9","key":"1855_CR39","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/jps.20874","volume":"96","author":"T Ozben","year":"2007","unstructured":"Ozben T (2007) Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 96(9):2181\u20132196","journal-title":"J Pharm Sci"},{"issue":"1","key":"1855_CR40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0305-7372(79)80057-2","volume":"6","author":"AW Prestayko","year":"1979","unstructured":"Prestayko AW, D'aoust JC, Issell BF, Crooke ST (1979) Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev 6(1):17\u201339","journal-title":"Cancer Treat Rev"},{"key":"1855_CR41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mrgentox.2018.01.009","volume":"828","author":"MM Rageh","year":"2018","unstructured":"Rageh MM, El-Gebaly RH (2018) Melanin nanoparticles: antioxidant activities and effects on \u03b3-ray-induced DNA damage in the mouse. Mutation Research\/Genetic Toxicology and Environmental Mutagenesis 828:15\u201322","journal-title":"Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"},{"issue":"3","key":"1855_CR42","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1007\/s11033-019-04769-9","volume":"46","author":"MM Rageh","year":"2019","unstructured":"Rageh MM, El-Gebaly RH (2019) Antioxidant activities of \u03b1-lipoic acid free and nano-capsule inhibit the growth of Ehrlich carcinoma. Mol Biol Rep 46(3):3141\u20133148","journal-title":"Mol Biol Rep"},{"issue":"8","key":"1855_CR43","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/0006-2952(92)90725-X","volume":"43","author":"Y Sadzuka","year":"1992","unstructured":"Sadzuka Y, Shoji T, Takino Y (1992) Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochem Pharmacol 43(8):1872\u20131875","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"1855_CR44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00204-006-0173-2","volume":"81","author":"NAG Santos","year":"2007","unstructured":"Santos NAG, Catao CS, Martins NM, Curti C, Bianchi MDLP, Santos ACD (2007) Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Arch Toxicol 81(7):495\u2013504","journal-title":"Arch Toxicol"},{"issue":"1","key":"1855_CR45","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13287-018-0946-6","volume":"9","author":"IO Sherif","year":"2018","unstructured":"Sherif IO, Sabry D, Abdel-Aziz A, Sarhan OM (2018) The role of mesenchymal stem cells in chemotherapy-induced gonadotoxicity. Stem Cell Res Ther 9(1):196","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1855_CR46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7\u201334","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"1855_CR47","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2174\/092986707780362835","volume":"14","author":"M Simk\u00f3","year":"2007","unstructured":"Simk\u00f3 M (2007) Cell type specific redox status is responsible for diverse electromagnetic field effects. Curr Med Chem 14(10):1141\u20131152","journal-title":"Curr Med Chem"},{"issue":"1","key":"1855_CR48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jcb.20198","volume":"93","author":"M Simk\u00f3","year":"2004","unstructured":"Simk\u00f3 M, Mattsson MO (2004) Extremely low frequency electromagnetic fields as effectors of cellular responses in vitro: possible immune cell activation. J Cell Biochem 93(1):83\u201392","journal-title":"J Cell Biochem"},{"issue":"1","key":"1855_CR49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","volume":"175","author":"NP Singh","year":"1988","unstructured":"Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175(1):184\u2013191","journal-title":"Exp Cell Res"},{"issue":"12","key":"1855_CR50","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/09553002.2019.1524943","volume":"94","author":"Y Sun","year":"2018","unstructured":"Sun Y, Shi Z, Wang Y, Tang C, Liao Y, Yang C, Cai P (2018) Coupling of oxidative stress responses to tricarboxylic acid cycle and prostaglandin E2 alterations in Caenorhabditis elegans under extremely low-frequency electromagnetic field. Int J Radiat Biol 94(12):1159\u20131166","journal-title":"Int J Radiat Biol"},{"issue":"3","key":"1855_CR51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","volume":"35","author":"RR Tice","year":"2000","unstructured":"Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel\/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35(3):206\u2013221","journal-title":"Environ Mol Mutagen"},{"issue":"6","key":"1855_CR52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/bem.69","volume":"22","author":"S Tofani","year":"2001","unstructured":"Tofani S, Barone D, Cintorino M, de Santi MM, Ferrara A, Orlassino R et al (2001) Static and ELF magnetic fields induce tumor growth inhibition and apoptosis. Bioelectromagnetics: Journal of the Bioelectromagnetics Society, The Society for Physical Regulation in Biology and Medicine, The European Bioelectromagnetics Association 22(6):419\u2013428","journal-title":"Bioelectromagnetics: Journal of the Bioelectromagnetics Society, The Society for Physical Regulation in Biology and Medicine, The European Bioelectromagnetics Association"},{"issue":"1","key":"1855_CR53","first-page":"83","volume":"48","author":"S Tofani","year":"2003","unstructured":"Tofani S, Barone D, Berardelli M, Berno E, Cintorino M, Foglia L, Ossola P, Ronchetto F, Toso E, Eandi M (2003) Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against Lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma. Pharmacol Res 48(1):83\u201390","journal-title":"Pharmacol Res"},{"issue":"5","key":"1855_CR54","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.fertnstert.2007.04.059","volume":"89","author":"G T\u00fcrk","year":"2008","unstructured":"T\u00fcrk G, Ate\u015f\u015fahin A, S\u00f6nmez M, \u00c7eriba\u015fi AO, Y\u00fcce A (2008) Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid. Fertil Steril 89(5):1474\u20131481","journal-title":"Fertil Steril"},{"issue":"2","key":"1855_CR55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1043-6618(02)00282-7","volume":"47","author":"Z Yildirim","year":"2003","unstructured":"Yildirim Z, Sogut S, Odaci E, Iraz M, Ozyurt H, Kotuk M, Akyol O (2003) Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol Res 47(2):149\u2013156","journal-title":"Pharmacol Res"},{"issue":"5","key":"1855_CR56","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bcp.2010.11.016","volume":"81","author":"A Yonezawa","year":"2011","unstructured":"Yonezawa A, Inui KI (2011) Organic cation transporter OCT\/SLC22A and H+\/organic cation antiporter MATE\/SLC47A are key molecules for nephrotoxicity of platinum agents. Biochem Pharmacol 81(5):563\u2013568","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1855_CR57","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/scrt194","volume":"4","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Xu H, Xu W, Wang B, Wu H, Tao Y et al (2013) Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther 4(2):34","journal-title":"Stem Cell Res Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01855-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-020-01855-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01855-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:09:52Z","timestamp":1616285392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-020-01855-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,21]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1855"],"URL":"https:\/\/doi.org\/10.1007\/s00210-020-01855-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,21]]},"assertion":[{"value":"26 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}